[Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO).]. [electronic resource]
- Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
- 446-56 p. digital
Angiotensin II Type 1 Receptor Blockers--therapeutic use Angiotensin Receptor Antagonists--therapeutic use Angiotensin-Converting Enzyme Inhibitors--therapeutic use Cardiovascular Diseases Humans Prospective Studies Risk Factors